ConductScience.org, home

Trial · NCT00820352

Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension

NCT00820352, Phase 3, Completed, University Teaching Hospital Hall in Tirol

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension. Trials, record NCT00820352. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00820352

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
NCT number
NCT00820352
Status
Completed
Phases
Phase 3
Enrollment
20 participants, actual
Lead sponsor
University Teaching Hospital Hall in Tirol
Conditions
Heart Failure, Diastolic, Hypertension, Pulmonary
Interventions
bosentan, placebo
First posted
2009-01-12
Last updated
2014-06-30
Other registries' IDs
eudract:2008-005514-40

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarychange in 6 minute waling distance after 12 weeks of bosentan (or placebo) treatment12 weeks
Secondarychange in 6 minute walking distance after 24 weeks (12 weeks bosentan or placebo treatment and 12 weeks follow-up)24 weeks
Secondarychanges in hemodynamics assessed by echocardiography after 12 and 24 weeks24 weeks
Secondarytime to clinical worsening after 12 and 24 weeks24 weeks
Secondarylevels of NTpBNP, CRP and Endothelin-1 after 12 and 24 weeks24 weeks
SecondaryQuality of Life assessment (SF-36 and Minnesota Living With Heart Failure Score) after 12 and 24 weeks24 weeks
SecondaryAdverse event count after 12 and 24 weeks24 weeks

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers20

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
10027861BACKGROUNDPubMed
10217651BACKGROUNDPubMed
11015353BACKGROUNDPubMed
11549299BACKGROUNDPubMed
11907289BACKGROUNDPubMed
12853530BACKGROUNDPubMed
14736539BACKGROUNDPubMed
15642529BACKGROUNDPubMed
16387829BACKGROUNDPubMed
16801459BACKGROUNDPubMed

1 to 10 of 20

See all 20 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00820352

GET https://conductscience.org/api/trials/v1/NCT00820352/registered